Studying celiac disease and related gut conditions
Part of Digestive system, Hormones & metabolism clinical trials.
This study collects information from people being checked for celiac disease to better understand the condition and improve diagnosis and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being evaluated for celiac disease
- You are willing to sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at adults with immune-related stomach and intestine problems to better understand what may cause them. If you qualify, you can share information and consent to help researchers learn how these conditions work.
This study aims to improve how doctors diagnose celiac disease by looking at your blood test and biopsy results together. It may help create a more personalized diagnosis for people being evaluated for celiac disease.
This study helps people newly diagnosed with celiac disease learn to use a gluten-detection device and get education to better manage their diet and health.
This study tests an experimental medication for adults with celiac disease to see if it can protect against gluten exposure. You will need to follow a gluten-free diet and undergo a short, planned gluten challenge.
This research study examines tissue samples from your small bowel (the part of your digestive system after your stomach) to better understand celiac disease and related conditions. By studying these samples in detail, researchers hope to improve how doctors diagnose and treat small-bowel diseases.
This study looks at how gut bacteria, diet, and family background may relate to celiac disease risk in very young infants. It may help researchers understand why celiac disease happens and how it could be prevented or detected earlier.
Hear when a new Celiac Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.